88.20USD-1.35%Mkt Cap: 12.59B $P/E: —Today
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasir…
Industry Peers
Biotechnology$130.23BUSDP/E 32.1
$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$61.34BUSDP/E 39.8
$45.95BUSDP/E 19.6
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$20.83BUSDP/E 26.3
$19.26BUSDP/E 26.6
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
Key Statistics
Company
Market Cap12.59B $
Enterprise Value12.14B $
Revenue (TTM)669.49M $
Gross Profit669.49M $
Net Income (TTM)-1.63M $
Revenue/Share4.766 USD
Last Price88.20 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees711
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS04280A1007
Valuation
P/E (Trailing)—
P/E (Forward)-17.97
PEG—
EV/EBITDA-60.50
EV/Revenue18.13
P/S18.45
P/B26.52
EPS (TTM)-2.23
EPS (Forward)-4.87
52W Range
18.7391% of range95.49
52W High95.49 USD
52W Low18.73 USD
Profitability
Gross Margin100.00%
Oper. Margin-226.03%
EBITDA Margin-29.97%
Profit Margin-0.20%
ROE-0.35%
ROA-0.12%
Growth
Revenue Growth171.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF179.55M $
CapEx (TTM)22.67M $
FCF Margin-7.26%
FCF Yield-0.39%
Net Debt-218.45M $
Net Debt/EBITDA1.09
Balance Sheet
Debt/Equity0.79
Current Ratio5.90
Quick Ratio5.71
Book Value/Sh3.298 USD
Cash/Share11.31 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateNov 17, 2011
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)110.18 USD
Upside (mean)+24.9%
Target Range100.00 USD – 126.00 USD
$100.00+24.9% to mean$126.00
# Analysts11
Ownership
Shares Out.140.86M
Float122.45M
Insiders3.67%
Institutions85.57%
Short Interest
Short Ratio4.2d
Short % Float9.51%
Short % Out.6.84%
Shares Short9.66M
Short (prev mo.)8.43M
Technical
SMA 5082.18 (+7.3%)
SMA 20068.60 (+28.6%)
Beta1.29
S&P 52W Chg18.16%
Avg Vol (30d)1.88M
Avg Vol (10d)1.00M
Technical Indicators
RSI (14)59.5
MACD2.1333
MACD Signal2.1996
MACD Hist.-0.0663
BB Upper90.05 USD
BB Middle87.09 USD
BB Lower84.12 USD
BB Width6.81%
ATR (14)3.614 USD
Vol Ratio (20d)0.72x